These hypothesis generating observations underscore the need for future studies to examine whether targeting MAA (with RASPi or through other agents) or MAA-specific downstream pathways could attenuate RA and its complications or prevent the development of RA in high risk individuals. The gene discussed is NAA10; the disease is rheumatoid arthritis.